Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments

por Casey, J L, Pedley, R B, King, D J, Green, A J, Yarranton, G T, Begent, R H J
Publicado 1999

Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.

por Casey, J. L., King, D. J., Chaplin, L. C., Haines, A. M., Pedley, R. B., Mountain, A., Yarranton, G. T., Begent, R. H.
Publicado 1996

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).

por Antoniw, P., Farnsworth, A. P., Turner, A., Haines, A. M., Mountain, A., Mackintosh, J., Shochat, D., Humm, J., Welt, S., Old, L. J., Yarranton, G. T., King, D. J.
Publicado 1996

Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study

por Casey, J L, Napier, M P, King, D J, Pedley, R B, Chaplin, L C, Weir, N, Skelton, L, Green, A J, Hope-Stone, L D, Yarranton, G T, Begent, R H J
Publicado 2002